Strain Profile
Save

Lactobacillus rhamnosus CNCM I-3690

◐ Food-origin
Sequenced
Public genome assembly available

Lacticaseibacillus rhamnosus CNCM I-3690 has been studied across a range of outcomes with a mix of animal, in vitro, and human RCT evidence. Animal studies have examined the strain's relationship to intestinal barrier integrity, mucus production, and cytoprotective responses, and one study examined lifespan in a Caenorhabditis elegans oxidative-stress model. Multiple randomized controlled trials evaluated CNCM I-3690 as part of multi-strain fermented milk formulations, examining gut microbiota recovery after Helicobacter pylori antibiotic therapy and microbiome resilience. A separate human RCT examined subjective stress scores in healthy adults in connection with gut-brain axis activity. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.

Where it's been studied

Share of this strain's 16 body-system-tagged papers that concern each system. Research coverage, not measured effect.

Symptoms in the research

Share of this strain's 8 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

+1 more symptoms

Research

16 papers reference this strain in the probiotic database.

Match confidence
2025 OBSERVATIONAL
Probiotic-mediated modulation of gut microbiome in students exposed to academic stress: a randomized controlled trial
· npj Biofilms and Microbiomes
2023 ANIMAL
Over-production of exopolysaccharide by Lacticaseibacillus rhamnosus CNCM I-3690 strain cutbacks its beneficial effect on the host
· Scientific Reports
2023 OBSERVATIONAL
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human
· Gut Microbes
2023 RCT
Endogenous small intestinal microbiome determinants of transient colonisation efficiency by bacteria from fermented dairy products: a randomised controlled trial
· Microbiome
2022 RCT
Improved gut microbiome recovery following drug therapy is linked to abundance and replication of probiotic strains
· Gut Microbes
2022 RCT
Lactobacillus rhamnosus CNCM I-3690 decreases subjective academic stress in healthy adults: a randomized placebo-controlled trial
· Gut Microbes
2021 RCT
Multi-strain fermented milk promotes gut microbiota recovery after Helicobacter pylori therapy: a randomised, controlled trial
· medRxiv
2021 RCT
A Randomised, Controlled Trial: Effect of a Multi-Strain Fermented Milk on the Gut Microbiota Recovery after Helicobacter pylori Therapy
· Nutrients
2021 RCT
Endogenous Small Intestinal Microbiome Determinants of Transient Colonization Efficiency by Bacteria from Fermented Dairy Products; A Randomized Controlled Trial
· Research Square
2020 RCT
Safety and functional enrichment of gut microbiome in healthy subjects consuming a multi-strain fermented milk product: a randomised controlled trial
· Scientific Reports
2019 ANIMAL
The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response
· Scientific Reports
2014 ANIMAL
Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice
· Gut Microbes
2013 IN_VITRO
Caractérisation et analyse des effets probiotiques de souches de Lactobacillus et de Bifidobacterium
·
2012 ANIMAL
Anti-Inflammatory Lactobacillus rhamnosus CNCM I-3690 Strain Protects against Oxidative Stress and Increases Lifespan in Caenorhabditis elegans
· PLoS ONE
2018 ANIMAL
Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice
· Nature Communications
2017 ANIMAL
Impact de l'administration des probiotiques sur les infections respiratoires
· ZooKeys
Browse all 16 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    Probiotic-mediated modulation of gut microbiome in students exposed to academic stress: a randomized controlled trial
    · npj Biofilms and Microbiomes · 2025
    PMID 40691449 →
  2. [2]
    Endogenous small intestinal microbiome determinants of transient colonisation efficiency by bacteria from fermented dairy products: a randomised controlled trial
    · Microbiome · 2023
    PMID 36879297 →
  3. [3]
    Lactobacillus rhamnosus CNCM I-3690 decreases subjective academic stress in healthy adults: a randomized placebo-controlled trial
    · Gut Microbes · 2022
    PMID 35130109 →
  4. [4]
    Improved gut microbiome recovery following drug therapy is linked to abundance and replication of probiotic strains
    · Gut Microbes · 2022
    PMID 35916669 →
  5. [5]
    Endogenous Small Intestinal Microbiome Determinants of Transient Colonization Efficiency by Bacteria from Fermented Dairy Products; A Randomized Controlled Trial
    · Research Square · 2021
    Source →
  6. [6]
    A Randomised, Controlled Trial: Effect of a Multi-Strain Fermented Milk on the Gut Microbiota Recovery after Helicobacter pylori Therapy
    · Nutrients · 2021
    PMID 34579049 →
  7. [7]
    Multi-strain fermented milk promotes gut microbiota recovery after Helicobacter pylori therapy: a randomised, controlled trial
    · medRxiv · 2021
    Source →
  8. [8]
    Safety and functional enrichment of gut microbiome in healthy subjects consuming a multi-strain fermented milk product: a randomised controlled trial
    · Scientific Reports · 2020
    PMID 32994487 →